Nuvation Bio Ownership | Who Owns Nuvation Bio?
Nuvation Bio Ownership Summary
Nuvation Bio is owned by 65.95% institutional investors, 19.03% insiders, and 15.03% retail investors. Fmr is the largest institutional shareholder, holding 16.55% of NUVB shares.
NUVB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Nuvation Bio | 65.95% | 19.03% | 15.03% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 45.29M | 16.55% | $120.46M |
| Decheng capital | 25.95M | 7.62% | $50.61M |
| Blackrock funding, inc. /de | 25.73M | 7.55% | $50.18M |
| Blackrock | 16.24M | 7.41% | $47.41M |
| Vanguard group | 15.73M | 5.75% | $41.85M |
| Octagon capital advisors lp | 9.20M | 3.36% | $24.48M |
| Omega fund management | 11.04M | 3.24% | $21.53M |
| Laurion capital management lp | 10.24M | 3.01% | $19.97M |
| State street | 3.98M | 1.81% | $11.61M |
| Geode capital management | 4.95M | 1.81% | $13.17M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Omega fund management | 11.04M | 13.94% | $21.53M |
| Decheng capital | 25.95M | 12.78% | $50.61M |
| Octagon capital advisors lp | 9.20M | 4.03% | $24.48M |
| Edbi pte | 1.27M | 3.58% | $3.38M |
| Knoll capital management | 1.02M | 2.08% | $2.92M |
| Bioimpact capital | 4.62M | 1.56% | $9.01M |
| Aisling capital management lp | 2.54M | 1.38% | $4.95M |
| Ghost tree capital | 1.15M | 1.05% | $3.36M |
| Redmile group | 3.03M | 0.63% | $5.91M |
| Tang capital management | 3.90M | 0.38% | $7.61M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 45.29M | 0.01% | 16.05M |
| Blackrock funding, inc. /de | 25.73M | 0.00% | 7.25M |
| Vanguard group | 15.73M | 0.00% | 4.91M |
| Blackrock | 16.24M | 0.00% | 3.71M |
| Ubs group | 1.85M | 0.00% | 1.39M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ecor1 capital | - | - | -19.21M |
| Octagon capital advisors lp | 9.20M | 4.03% | -2.97M |
| Rosalind advisors | - | - | -2.45M |
| Omega fund management | 11.04M | 13.94% | -2.03M |
| Wexford capital lp | 81.59K | 0.04% | -691.33K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ghost tree capital | 1.15M | 1.05% | 1.15M | $3.36M |
| Natixis | 905.50K | 0.01% | 905.50K | $1.77M |
| Marshall wace, llp | 871.19K | 0.00% | 871.19K | $1.70M |
| Armistice capital | 500.00K | 0.02% | 500.00K | $975.00K |
| X-square capital | 310.00K | 0.22% | 310.00K | $605.00K |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -7.00 |
| Nelson, van denburg & campbell wealth management group | -28.00 |
| Lindbrook capital | -154.00 |
| Srs capital advisors | -234.00 |
| Corecap advisors | -237.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 184 | 14.29% | 224,710,788 | 8.38% | 65 | 1.76% | 122 | 64.86% | 30 | -42.31% |
| Mar 31, 2025 | 160 | - | 207,338,637 | 4.87% | 61 | 1.17% | 74 | -19.57% | 51 | 45.71% |
| Dec 31, 2024 | 148 | -5.13% | 179,374,596 | -4.45% | 65 | 1.39% | 83 | -3.49% | 35 | -2.78% |
| Sep 30, 2024 | 155 | 4.73% | 187,725,271 | 23.08% | 68 | 1.42% | 86 | -1.15% | 36 | -5.26% |
| Jun 30, 2024 | 148 | 19.35% | 152,519,595 | 13.28% | 69 | 1.84% | 87 | 29.85% | 38 | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 18, 2025 | Markel Stacy | CHIEF PEOPLE OFFICER | Buy | $17.10K |
| Jun 16, 2025 | Sauvage Philippe | Chief Financial Officer | Buy | $6.06K |
| Jun 17, 2025 | Sauvage Philippe | Chief Financial Officer | Buy | $7.16K |
| Jun 16, 2025 | Sjogren Colleen | Chief Commercial Officer | Buy | $90.35K |
| Jun 16, 2025 | Wentworth Kerry | CHIEF REGULATORY OFFICER | Buy | $43.20K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q2 | 11 | 1 |
| 2025 Q1 | - | - |
| 2024 Q4 | 2 | 1 |
| 2024 Q3 | - | - |
NUVB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools